Spero Therapeutics
SPRO
SPRO
46 hedge funds and large institutions have $16.5M invested in Spero Therapeutics in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
Holders
46
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$28.3K | |
| 2 | +$23K | |
| 3 | +$20.1K | |
| 4 |
PI
PFG Investments
Woodbury,
New York
|
+$18.7K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$13.4K |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$309K | |
| 3 | -$235K | |
| 4 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
-$177K |
| 5 |
Millennium Management
New York
|
-$88.9K |